BIOMAT Database Logo BIOMAT Database Logo

Tap (draft) beer and monoamine oxidase inhibitor dietary restrictions. 1997

K I Shulman, and S A Tailor, and S E Walker, and D M Gardner
Department of Psychiatry, University of Toronto, Ontario.

OBJECTIVE Traditional monoamine oxidase inhibitors (MAOIs) continue to play an important role in the management of a wide variety of clinical conditions. Accordingly, a practical and safe approach to MAOI dietary restrictions remains an essential component of patient management. METHODS In an effort to refine MAOI dietary recommendations, we report a case of hypertensive crisis following the consumption of a modest amount of tap beer. RESULTS A well-documented case report involving tap (draft) beer consumed while on an MAOI supports an earlier study, which recommended that all tap beers be restricted on MAOI diets. The 2 cases were remarkably similar in terms of the offending substance, quantity consumed, and subsequent reaction. CONCLUSIONS As a result of recent tyramine analyses and 2 well-documented case reports, all tap (draft) beers should now be absolutely restricted on MAOI diets because they represent a very significant risk at modest levels of consumption.

UI MeSH Term Description Entries
D006974 Hypertension, Malignant A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction. Malignant Hypertension
D008297 Male Males
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D010624 Phenelzine One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC. Fenelzin,2-Phenethylhydrazine,Nardelzine,Nardil,Phenelzine Sulfate,Phenethylhydrazine,beta-Phenylethylhydrazine,2 Phenethylhydrazine,Sulfate, Phenelzine,beta Phenylethylhydrazine
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075202 Contraindications A condition or factor associated with a recipient that makes the use of a drug, procedure, or physical agent improper or inadvisable. Contraindications may be absolute (life threatening) or relative (higher risk of complications in which benefits may outweigh risks). Contraindications, Physical Agent,Medical Contraindications,Agent Contraindication, Physical,Agent Contraindications, Physical,Contraindication,Contraindication, Medical,Contraindication, Physical Agent,Contraindications, Medical,Medical Contraindication,Physical Agent Contraindication,Physical Agent Contraindications
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K I Shulman, and S A Tailor, and S E Walker, and D M Gardner
[Moclobemide (Aurorix). A new monoamine oxidase inhibitor not requiring dietary restrictions].
February 1991, Ugeskrift for laeger,
K I Shulman, and S A Tailor, and S E Walker, and D M Gardner
Monoamine oxidase inhibitor dietary restrictions: what are we asking patients to give up?
May 1995, The Journal of clinical psychiatry,
K I Shulman, and S A Tailor, and S E Walker, and D M Gardner
Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.
January 2012, The Journal of clinical psychiatry,
K I Shulman, and S A Tailor, and S E Walker, and D M Gardner
Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art.
January 2007, The Journal of clinical psychiatry,
K I Shulman, and S A Tailor, and S E Walker, and D M Gardner
Alcohol-free beer and the irreversible monoamine oxidase inhibitors.
January 1992, International clinical psychopharmacology,
K I Shulman, and S A Tailor, and S E Walker, and D M Gardner
Monoamine oxidase inhibitor overdose.
April 1997, The Western journal of medicine,
K I Shulman, and S A Tailor, and S E Walker, and D M Gardner
Monoamine oxidase inhibitor overdose.
December 1984, Annals of emergency medicine,
K I Shulman, and S A Tailor, and S E Walker, and D M Gardner
Monoamine oxidase inhibitor toxicity.
November 1989, Journal of the American Academy of Child and Adolescent Psychiatry,
K I Shulman, and S A Tailor, and S E Walker, and D M Gardner
New inhibitor of monoamine oxidase.
September 1960, Nature,
K I Shulman, and S A Tailor, and S E Walker, and D M Gardner
Monoamine oxidase inhibitor-responsive depression.
February 1982, Psychiatry research,
Copied contents to your clipboard!